Rocuronium resistance associated with rivastigmine transdermal therapy

Lignende værker

• Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer’s disease
  af: Gustavo Alves Andrade dos Santos, et al.
  Udgivet: (2011)
• Rivastigmine–Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors
  af: Jie Wu, et al.
  Udgivet: (2023-12-01)
• The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease
  af: Elena Evgenyevna Vasenina, et al.
  Udgivet: (2012-09-01)
• A prospective study on the use of rivastigmine transdermal patch in Alzheimer's dementia in a routine clinical setting
  af: Ejaz Nazir, et al.
• Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo‐controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease
  af: Mitsunori Watanabe, et al.
  Udgivet: (2019-01-01)